Intus Biosciences LLC

Farmington, CT Doing business as Shoreline Biome LLC

UEI
CJ9VLH9CVBJ4
CAGE
79QC8
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
400 Farmington Ave, Farmington, CT 06032, USA
Website
intusbio.com
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Intus Biosciences LLC's 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Non-invasive, bacterial-based early-onset colorectal screen - project summary/abstract early-onset colorectal cancer… Grant · R44CA314644 National Cancer Institute $404,338
Breakthrough high-accuracy, high-throughput colorectal cancer screening platform - project summary/abstract screening… Grant · R43CA298515 National Cancer Institute $405,973
High resolution microbiome profiling system Grant · R43DA043947 National Institute on Drug Abuse $224,971

Quick answers

What is Intus Biosciences LLC's UEI?

Intus Biosciences LLC's Unique Entity ID (UEI) in SAM.gov is CJ9VLH9CVBJ4.

What is Intus Biosciences LLC's CAGE code?

Intus Biosciences LLC's CAGE code is 79QC8.

Where is Intus Biosciences LLC located?

Intus Biosciences LLC's physical address in SAM.gov is 400 Farmington Ave, Farmington, CT 06032, USA.

Is Intus Biosciences LLC registered in SAM.gov?

Yes. Intus Biosciences LLC's SAM.gov registration is active through December 29, 2026.

What is Intus Biosciences LLC's most recent federal award?

Intus Biosciences LLC's most recent federal grant award is Non-invasive, bacterial-based early-onset colorectal screen - project summary/abstract early-onset colorectal cancer… (R44CA314644), from National Cancer Institute, on August 19, 2026.

On GovTribe

See Intus Biosciences LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login